MindMed Announces Rebrand to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026 ...
Objectives to describe the evolution of anxiety during the COVID-19 pandemic in France and to assess whether it differed according to pre-existing alcohol misuse. Design A prospective longitudinal ...
South Korean President Lee Jae Myung said on Wednesday that much progress had been made in restoring trust with Beijing, and ...
The White House said Tuesday that “U.S. military is always an option,” even as a series of European leaders rejected ...
Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric ...
Province's PM urges 'no more fantasies about annexation'; Danish premier says 'we will not accept' suggestions of a takeover, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback